Baseline PSMA tumor volume as a prognostic marker in radical radiotherapy for prostate cancer: a propensity score-weighted retrospective analysis
Our findings highlight PSMA-TV as an independent predictor of treatment failure following definitive RT in PCa, supporting its potential role as a risk-stratifying biomarker, paving the way for individualized therapeutic strategies. Prospective validation is warranted to confirm its clinical utility and guide future radiotherapy personalization.
Authors
- Silvia Chiola (ORCID: https://orcid.org/0000-0003-3861-1248)
- Stefano Raffa
- Roberto Piva (ORCID: https://orcid.org/0000-0002-2273-3470)
- Giorgia Timon (ORCID: https://orcid.org/0000-0002-1555-0940)
- Maria Isabella Donegani (ORCID: https://orcid.org/0000-0003-1736-8410)
- Gianmario Sambuceti (ORCID: https://orcid.org/0000-0003-2979-6500)
- Antonio Catanoso
- S. Mastrogiovanni (ORCID: https://orcid.org/0000-0003-1606-4183)
- Matteo Bauckneht (ORCID: https://orcid.org/0000-0002-1937-9116)
- Francesco Lanfranchi (ORCID: https://orcid.org/0000-0002-6043-9627)
- Mattia Riondato (ORCID: https://orcid.org/0000-0001-9046-7170)
- Liliana Belgioia (ORCID: https://orcid.org/0000-0003-0508-6344)
- Cecilia Marini (ORCID: https://orcid.org/0000-0003-1682-578X)
- Salvina Barra
- Michela Marcenaro
- D. Vita
- Luca Sofia
- Valentina Pau
- Jacopo Passoni
Institutions
- Institute of Molecular Bioimaging and Physiology (IT)
- Ospedale Policlinico San Martino (IT)
- University of Genoa (IT)
Publication Details
- Journal
- Annals of Nuclear Medicine
- Published
- 2025-10-10
- DOI
- https://doi.org/10.1007/s12149-025-02118-4
- Citations
- 2
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 3.04